Advertisment

Oral Suspension

Strides gets USFDA nod for generic drug with 180-day exclusivity

Strides gets USFDA nod for generic drug with 180-day exclusivity

Drug firm Strides Pharma Science on Saturday said its subsidiary has received approval from the US health regulator to market Ibuprofen Oral Suspension, used for the treatment of
Advertisment
Subscribe